LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.42 | 17.25 | 170 | 3895 | 0.0436 | 0.3399 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 44.42 | 17.25 | 880 | 3895 | 0.2259 | 0.6535 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.39 | 17.25 | 17 | 4141 | 0.0041 | -0.0019 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.39 | 17.25 | 769 | 4141 | 0.1857 | 0.6164 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.39 | 17.25 | 139 | 4141 | 0.0336 | 0.3020 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 46.39 | 17.25 | 872 | 4141 | 0.2106 | 0.6423 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.36 | 17.25 | 23 | 4390 | 0.0052 | 0.0366 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.36 | 17.25 | 747 | 4390 | 0.1702 | 0.6024 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.36 | 17.25 | 81 | 4390 | 0.0185 | 0.2135 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.36 | 17.25 | 855 | 4390 | 0.1947 | 0.6297 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.33 | 17.25 | 25 | 4651 | 0.0054 | 0.0470 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.33 | 17.25 | 741 | 4651 | 0.1593 | 0.5931 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.33 | 17.25 | 72 | 4651 | 0.0155 | 0.1936 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.33 | 17.25 | 846 | 4651 | 0.1819 | 0.6194 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.30 | 17.25 | 15 | 4798 | 0.0031 | -0.0171 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.30 | 17.25 | 739 | 4798 | 0.1540 | 0.5884 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.30 | 17.25 | 80 | 4798 | 0.0167 | 0.2080 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.30 | 17.25 | 861 | 4798 | 0.1794 | 0.6186 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 54.27 | 17.25 | 19 | 4884 | 0.0039 | 0.0119 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 54.27 | 17.25 | 735 | 4884 | 0.1505 | 0.5851 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 54.27 | 17.25 | 78 | 4884 | 0.0160 | 0.2035 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 54.27 | 17.25 | 831 | 4884 | 0.1701 | 0.6092 | MN20160310_N02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 56.24 | 17.25 | 18 | 4929 | 0.0037 | 0.0052 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 56.24 | 17.25 | 726 | 4929 | 0.1473 | 0.5815 | MN20160310_N02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 56.24 | 17.25 | 66 | 4929 | 0.0134 | 0.1788 | MN20160310_N02 | N03 |